RE:RE:RE:Conference callG1945V wrote: WalkOverTheStrt wrote: I've personally spoken to Hugh (3 weeks ago) and came away impressed. He in 6 weeks has ramped up incredibly quickly and accomplished some decent early wins/steps. I believe he has the right vision and sales-brand- marketing strategy to get sales ramped. I wasn't impressed with GA or Alvira if that gives any context. I expect 2024 to slowly proceed with some potential wild cards to help drive the stock price but am conservatively looking at 2025 for the real movements.
Isn't Hugh an interim CEO? G1945V
Toronto, Ontario – February 13, 2024 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT)(OTCVPTDF) announces changes to the Board of Directors.
With the recent appointment of Hugh MacNaught as Interim CEO and President, the composition of board committees has been adjusted as follows:.
Nominating and Corporate Governance Committee: Dr. George Adams (chair), Robert Hodgkinson, Hugh MacNaught
Compensation Committee: Fiona Fitzgerald, Randy Aucoin
Audit Committee: Robert Hodgkinson (chair), Randy AuCoin, George Adams,
Further, Dr. Alvira Macanovic has resigned as a director of the Company effective February 12, 2024.